Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands.
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2493-2507. doi: 10.1016/j.jcin.2016.09.044.
The study sought to determine the incidence, predictors, characteristics, and outcomes of repeat revascularization during 5-year follow-up of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) trial.
Limited in-depth long-term data on repeat revascularization are available from randomized trials comparing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Incidence and timing of repeat revascularization and its relation to the long-term composite safety endpoint of death, stroke, and myocardial infarction were analyzed in the SYNTAX trial (n = 1,800) using Kaplan-Meier analysis.
At 5 years, repeat revascularization occurred more often after initial PCI than after initial CABG (25.9% vs. 13.7%, respectively; p < 0.001), and more often consisted of multiple repeat revascularizations (9.0% vs. 2.8%, respectively; p = 0.022). Significantly more repeat PCI procedures were performed on de novo lesions in patients after initial PCI than initial CABG (33.3% vs. 13.4%, respectively; p < 0.001). At 5-year follow-up, patients who underwent repeat revascularization versus patients not undergoing repeat revascularization had significantly higher rates of the composite safety endpoint of death, stroke, and myocardial infarction after initial PCI (33.8% vs. 16.6%, respectively; p < 0.001), and a trend was found after initial CABG (22.4% vs. 15.8%, respectively; p = 0.07). After multivariate adjustment, repeat revascularization was an independent predictor of the composite safety endpoint after both initial PCI (hazard ratio [HR]: 2.2; 95% confidence interval [CI]: 1.6 to 3.0; p < 0.001) and initial CABG (HR: 1.8; 95% CI: 1.2 to 2.9; p = 0.011).
Repeat revascularization rates are significantly higher after initial PCI than after initial CABG for complex coronary disease. Repeat revascularization is an independent predictor of death, stroke, and myocardial infarction for myocardial revascularization.
本研究旨在确定 SYNTAX(经皮冠状动脉介入治疗与紫杉醇和心脏手术的协同作用)试验 5 年随访期间重复血运重建的发生率、预测因素、特征和结局。
比较经皮冠状动脉介入治疗(PCI)与冠状动脉旁路移植术(CABG)的随机试验提供的重复血运重建的深入长期数据有限。
使用 Kaplan-Meier 分析对 SYNTAX 试验(n=1800)中重复血运重建的发生率和时间及其与死亡、卒中和心肌梗死的长期复合安全终点的关系进行分析。
在 5 年时,初始 PCI 后重复血运重建的发生率高于初始 CABG(分别为 25.9%和 13.7%;p<0.001),且更多为多次重复血运重建(分别为 9.0%和 2.8%;p=0.022)。与初始 CABG 相比,初始 PCI 后重复 PCI 术更多地应用于新发病变(分别为 33.3%和 13.4%;p<0.001)。在 5 年随访时,与未进行重复血运重建的患者相比,进行重复血运重建的患者初始 PCI 后死亡、卒中和心肌梗死的复合安全终点发生率显著更高(分别为 33.8%和 16.6%;p<0.001),且初始 CABG 后也有此趋势(分别为 22.4%和 15.8%;p=0.07)。多变量调整后,重复血运重建是初始 PCI(危险比[HR]:2.2;95%置信区间[CI]:1.6 至 3.0;p<0.001)和初始 CABG(HR:1.8;95%CI:1.2 至 2.9;p=0.011)后复合安全终点的独立预测因素。
对于复杂的冠状动脉疾病,初始 PCI 后重复血运重建的发生率明显高于初始 CABG。重复血运重建是心肌血运重建后死亡、卒中和心肌梗死的独立预测因素。